CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 143 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $7,541,000 | +34.8% | 265,045 | 0.0% | 0.29% | +35.6% |
| Q4 2017 | $5,595,000 | -41.9% | 265,045 | -50.0% | 0.22% | -37.2% |
| Q3 2017 | $9,632,000 | +17.2% | 530,092 | 0.0% | 0.34% | +13.2% |
| Q2 2017 | $8,216,000 | -10.3% | 530,092 | 0.0% | 0.30% | -14.4% |
| Q1 2017 | $9,155,000 | +10.2% | 530,092 | -29.9% | 0.36% | +0.3% |
| Q4 2016 | $8,309,000 | -29.9% | 756,090 | 0.0% | 0.35% | -22.4% |
| Q3 2016 | $11,855,000 | +53.5% | 756,090 | 0.0% | 0.46% | +44.8% |
| Q2 2016 | $7,723,000 | +82.5% | 756,090 | +130.5% | 0.32% | +75.0% |
| Q1 2016 | $4,232,000 | -38.2% | 328,059 | 0.0% | 0.18% | -27.4% |
| Q4 2015 | $6,847,000 | – | 328,059 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,500,000 | $7,635,000 | 1.78% |
| Altium Capital Management LP | 1,233,642 | $6,279,000 | 1.65% |
| RA Capital Management | 3,500,000 | $17,815,000 | 0.25% |
| Soleus Capital Management, L.P. | 261,050 | $1,329,000 | 0.21% |
| Affinity Asset Advisors, LLC | 125,000 | $636,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,103 | $5,488,000 | 0.16% |
| Point72 Asset Management, L.P. | 6,303,025 | $32,082,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 249,146 | $1,268,000 | 0.13% |
| Candriam S.C.A. | 3,305,940 | $16,826,000 | 0.11% |
| RTW INVESTMENTS, LP | 1,400,939 | $7,131,000 | 0.11% |